APLT
Price
$0.32
Change
-$0.06 (-15.79%)
Updated
Jun 27 closing price
Capitalization
48.43M
39 days until earnings call
COEP
Price
$7.78
Change
-$0.25 (-3.11%)
Updated
Jun 27 closing price
Capitalization
27.34M
Interact to see
Advertisement

APLT vs COEP

Header iconAPLT vs COEP Comparison
Open Charts APLT vs COEPBanner chart's image
Applied Therapeutics
Price$0.32
Change-$0.06 (-15.79%)
Volume$13.33M
Capitalization48.43M
Coeptis Therapeutics Holdings
Price$7.78
Change-$0.25 (-3.11%)
Volume$17.97K
Capitalization27.34M
APLT vs COEP Comparison Chart in %
Loading...
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLT vs. COEP commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLT is a Hold and COEP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (APLT: $0.32 vs. COEP: $7.78)
Brand notoriety: APLT and COEP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLT: 571% vs. COEP: 29%
Market capitalization -- APLT: $48.43M vs. COEP: $27.34M
APLT [@Biotechnology] is valued at $48.43M. COEP’s [@Biotechnology] market capitalization is $27.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLT’s FA Score shows that 0 FA rating(s) are green whileCOEP’s FA Score has 0 green FA rating(s).

  • APLT’s FA Score: 0 green, 5 red.
  • COEP’s FA Score: 0 green, 5 red.
According to our system of comparison, COEP is a better buy in the long-term than APLT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLT’s TA Score shows that 4 TA indicator(s) are bullish while COEP’s TA Score has 3 bullish TA indicator(s).

  • APLT’s TA Score: 4 bullish, 4 bearish.
  • COEP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, APLT is a better buy in the short-term than COEP.

Price Growth

APLT (@Biotechnology) experienced а -5.57% price change this week, while COEP (@Biotechnology) price change was +2.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

APLT is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLT($48.4M) has a higher market cap than COEP($27.3M). COEP YTD gains are higher at: 41.455 vs. APLT (-62.182). COEP has higher annual earnings (EBITDA): -9.95M vs. APLT (-108.32M). APLT has more cash in the bank: 50.8M vs. COEP (4.27M). COEP has less debt than APLT: COEP (2.04M) vs APLT (2.7M). APLT has higher revenues than COEP: APLT (265K) vs COEP (62.9K).
APLTCOEPAPLT / COEP
Capitalization48.4M27.3M177%
EBITDA-108.32M-9.95M1,089%
Gain YTD-62.18241.455-150%
P/E RatioN/AN/A-
Revenue265K62.9K421%
Total Cash50.8M4.27M1,190%
Total Debt2.7M2.04M132%
FUNDAMENTALS RATINGS
APLT vs COEP: Fundamental Ratings
APLT
COEP
OUTLOOK RATING
1..100
760
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
9444
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APLT's Valuation (53) in the null industry is in the same range as COEP (72). This means that APLT’s stock grew similarly to COEP’s over the last 12 months.

COEP's Profit vs Risk Rating (95) in the null industry is in the same range as APLT (100). This means that COEP’s stock grew similarly to APLT’s over the last 12 months.

APLT's SMR Rating (98) in the null industry is in the same range as COEP (99). This means that APLT’s stock grew similarly to COEP’s over the last 12 months.

COEP's Price Growth Rating (44) in the null industry is somewhat better than the same rating for APLT (94). This means that COEP’s stock grew somewhat faster than APLT’s over the last 12 months.

COEP's P/E Growth Rating (100) in the null industry is in the same range as APLT (100). This means that COEP’s stock grew similarly to APLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APLTCOEP
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
APLT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLMB103.332.89
+2.88%
Climb Global Solutions
NEMTF125.02N/A
N/A
Nemetschek AG
NE26.75-0.16
-0.59%
Noble Corp
SILA24.03-0.25
-1.03%
Sila Realty Trust Inc.
MLSS0.73-0.03
-4.34%
Milestone Scientific

APLT and

Correlation & Price change

A.I.dvisor tells us that APLT and AMGXF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLT and AMGXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLT
1D Price
Change %
APLT100%
-14.79%
AMGXF - APLT
32%
Poorly correlated
N/A
COEP - APLT
27%
Poorly correlated
-3.11%
BPMC - APLT
27%
Poorly correlated
-0.03%
EDIT - APLT
25%
Poorly correlated
+7.55%
TRVI - APLT
25%
Poorly correlated
-0.71%
More

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TVRD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TVRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
-3.11%
TVRD - COEP
38%
Loosely correlated
-2.38%
QRON - COEP
36%
Loosely correlated
N/A
NRXP - COEP
27%
Poorly correlated
-2.29%
APLT - COEP
26%
Poorly correlated
-14.79%
PDSB - COEP
25%
Poorly correlated
-2.76%
More